Helen of Troy Seen as High-Risk Stock With Early Stabilization Signs
Helen of Troy is framed as a high-risk, high-upside equity showing early progress on stabilization and deleveraging. The article points to 8% sales growth and net debt falling to $696 million, though leverage remains elevated at 3.5x EBITDA. It notes the company trades at 7x EBITDA with a $1.4 billion enterprise value, and further upside depends on reaching $2 billion in sales and 12–15% margins amid execution and tariff risks.
The piece revisits Helen of Troy after a steep share-price fall, noting that an opportunity thesis was already forming by late 2025. It highlights recent signs of operational improvement: sales rose 8%, and net debt was reduced to $696 million. Even so, leverage stays high at 3.5 times EBITDA.
The stock is described as trading at 7 times EBITDA, with a $1.4 billion enterprise value that sits below the company’s historical sales level. The article says more gains could come if Helen of Troy reaches $2 billion in sales and 12–15% margins, while execution challenges and tariff exposure remain major unknowns.
This story may matter most to investors holding a volatile, leveraged consumer-goods company, as well as creditors watching debt levels. If stabilization continues, it could support confidence among employees, suppliers, and business partners. If execution or tariff pressures worsen, the company’s financial stress may affect those same groups, potentially through cost pressures or reduced flexibility. Broader market observers may see it as a case study in high-risk turnarounds rather than a direct societal shift.